comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to this Section 12.2, the Disclosing Party will to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information. In addition to the foregoing, [***] may disclose [***] Confidential Information to Third Parties as reasonably required to facilitate the actual or potential Research, Development, Manufacture or Commercialization of [***] or Products; provided that such disclosure is covered by terms of confidentiality and non-use similar to those set forth herein. Notwithstanding anything to the contrary contained herein, in no event may [***] disclose [***] Confidential Information to any Third Party (including any of CRISPR’s investors, collaborators or licensees) engaged in the research, development, manufacture or commercialization of pharmaceutical products.
comply with Applicable Law. Comply with all applicable federal, state, or local laws applicable to any action or approval taken pursuant to this MOU.
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to this Section 14.2, the Disclosing Party will to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information.
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to this Section 12.2, the Disclosing Party will to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information. In addition to the foregoing and except as otherwise prohibited or limited by clause (b) of the following sentence, [***] may disclose [***] Confidential Information to Third Parties as reasonably required to facilitate the actual or potential Research, Development, Manufacture or Commercialization of Products; provided that such disclosure is covered by terms of confidentiality and non-use similar to those set forth herein. Notwithstanding anything to the contrary contained herein, (a) in no event may [***] disclose [***] Confidential Information to any Third Party (including any of [***] investors, collaborators or licensees) [***] as its primary business, and (b) in no event may [***] disclose [***] Confidential Information, other than the terms and conditions of this Agreement, to any Third Party (including any of [***] investors, collaborators or licensees) that [***] as its primary business.
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to this Section 9.2, the Disclosing Party shall to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential **** CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. CONFIDENTIAL TREATMENT REQUESTED treatment of such information. In addition to the foregoing, Aldeyra may disclose Xxxxxxxx’x Confidential Information to Third Parties in connection with the actual or potential Exploitation of Agreement Products; provided that such disclosure is covered by terms of confidentiality similar to those set forth herein. Notwithstanding anything to the contrary contained herein, in no event may Xxxxxxxx disclose Aldeyra’s Confidential Information to any Third Party (including any of Xxxxxxxx’x investors, collaborators or licensees) engaged in the Exploitation of an HSP90 Inhibitor for any indication which is being Exploited by Aldeyra.
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to this Section 9.2, the Disclosing Party shall to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information. In addition to the foregoing, Tarveda may disclose Xxxxxxxx’x Confidential Information to Third Parties in connection with the actual or potential Exploitation of Agreement Products or Diagnostic Products; provided that such disclosure is covered by terms of confidentiality similar to those set forth herein. Notwithstanding anything to the contrary contained herein, in no event may Xxxxxxxx disclose Tarveda’s Confidential Information to any Third Party (including any of Xxxxxxxx’x investors, collaborators or licensees) engaged in the Exploitation of a Competitive Product.
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party (or such Party’s Affiliate) pursuant to this Section 8.2, the Disclosing Party will to the extent possible give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information. Notwithstanding anything to the contrary contained herein, in no event may [***] disclose [***] Confidential Information regarding any Product, other than the terms and conditions of this Agreement, to any Third Party (including any of [***] investors, collaborators or licensees, including in reports and meetings) that [***] as its primary business.
comply with Applicable Law. Each Borrower shall do or cause to be done, and shall cause each of its Restricted Subsidiaries to do or cause to be done, all things necessary to comply with Applicable Law except where such non - compliance would not result in a Material Adverse Effect; (c) Corporate Existence . Except as provided in Section 8.02(d), each Borrower shall, and shall cause each of the Restricted Subsidiaries to, maintain its corporate existence in good standing and shall, and shall cause each of the Restricted Subsidiaries to, qualify and remain duly qualified to carry on business and own property in each jurisdiction in which such qualification is necessary, except where a failure to do so would not result in a Material Adverse Effect; (d)
comply with Applicable Law. Each Borrower shall do or cause to be done, and shall cause each of its Restricted Subsidiaries to do or cause to be done, all things necessary or desirable to comply with Applicable Law except where such non-compliance would not result in a Material Adverse Effect;
comply with Applicable Law. If a Party deems it reasonably necessary to disclose Confidential Information belonging to the other Party pursuant to Section 6.10.2(a) or Section 6.10.2(d), the Disclosing Party will, to the extent possible, give reasonable advance written notice of such disclosure to the other Party and take reasonable measures to ensure confidential treatment of such information. In addition to the foregoing, after the Closing, Buyer may disclose the Company’s Confidential Information to third parties in connection with the actual or potential research, development, manufacture or commercialization of Products; provided that such disclosure is covered by terms of confidentiality and non-use no less stringent than those set forth herein. Notwithstanding anything to the contrary contained herein, in no event may either Party disclose the other Party’s Confidential Information to any third party (including any of the Company’s investors, collaborators or licensees) engaged in the research, development, manufacture or commercialization of pharmaceutical products. Each Party shall be responsible for any breach of this Section 6.10 by any of its disclosees that would breach this Agreement if made by such Party. Notwithstanding anything in this Agreement to the contrary, following Closing, subject to confidentiality restrictions set forth in the UT Agreements, the Shareholders’ Representative shall be permitted to disclose information as required by law or to employees, advisors, agents or consultants of the Shareholders’ Representative and to the Company Holders, in each case who have a need to know such information, provided that such persons are subject to confidentiality obligations with respect thereto no less stringent than those set forth herein.
